Trial Outcomes & Findings for PharmacoMRI of Parkinson Disease (NCT NCT01528592)
NCT ID: NCT01528592
Last Updated: 2018-05-03
Results Overview
Correlation coefficient between UPDRS III score and independent components analysis network strength in left parietal cortex. UPDRS III is the Unified Parkinson's Disease Rating Scale composite motor score.
COMPLETED
NA
18 participants
1 hour
2018-05-03
Participant Flow
Recruitment period: 12/1/2011 - 4/30/2012 Location: Medical clinic in Chicago
Participant milestones
| Measure |
On / Off Medication
Subjects undergo MRI scanning in the medication off state and 1 hour after receiving medications.
|
|---|---|
|
Overall Study
STARTED
|
18
|
|
Overall Study
COMPLETED
|
18
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
PharmacoMRI of Parkinson Disease
Baseline characteristics by cohort
| Measure |
On / Off Medication
n=18 Participants
Subjects undergo MRI scanning in the medication off state and 1 hour after receiving medications.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
11 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
7 Participants
n=5 Participants
|
|
Age, Continuous
|
66.22 years
STANDARD_DEVIATION 8.71 • n=5 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
15 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
18 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 hourCorrelation coefficient between UPDRS III score and independent components analysis network strength in left parietal cortex. UPDRS III is the Unified Parkinson's Disease Rating Scale composite motor score.
Outcome measures
| Measure |
On / Off Medication
n=15 Participants
Subjects undergo MRI scanning in the medication off state and 1 hour after receiving medications.
|
|---|---|
|
Correlation Coefficient Between UPDRS III Score and Independent Components Analysis Network Strength in Left Parietal Cortex.
|
0.5869 unitless
|
Adverse Events
On / Off Medication
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place